Clinical Trial Update: Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol [Phase 3]

View source ↗

Summary

Phase 3 trial update on islet transplantation for Type 1 diabetes mellitus using the University of Illinois at Chicago protocol; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: CellTrans Inc. | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-04-06